A carregar...
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
BACKGROUND: Trastuzumab is a monoclonal antibody selectively directed against Her2 and approved for the treatment of Her2 overexpressing breast cancer patients. Its proposed mechanisms of action include mediation of antibody-dependent cellular cytotoxicity (ADCC) by triggering FcγRIII on natural kil...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2415031/ https://ncbi.nlm.nih.gov/pubmed/18485193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|